[
  {
    "ts": null,
    "headline": "Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher",
    "summary": "NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.",
    "url": "https://finnhub.io/api/news?id=ecf5e90678d317bae506f91c0cd47397ef21984fe4bbc917bc392245bf06d940",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763067720,
      "headline": "Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher",
      "id": 137476934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.",
      "url": "https://finnhub.io/api/news?id=ecf5e90678d317bae506f91c0cd47397ef21984fe4bbc917bc392245bf06d940"
    }
  },
  {
    "ts": null,
    "headline": "Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth?",
    "summary": "Cytokinetics' shares surge to a 52-week high as investor optimism grows over FDA approval prospects for aficamten.",
    "url": "https://finnhub.io/api/news?id=80f0d1b291b84524e6f2b095dbbe17981be73aa4676ca614ebf6e9986a83526e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763059560,
      "headline": "Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth?",
      "id": 137473249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Cytokinetics' shares surge to a 52-week high as investor optimism grows over FDA approval prospects for aficamten.",
      "url": "https://finnhub.io/api/news?id=80f0d1b291b84524e6f2b095dbbe17981be73aa4676ca614ebf6e9986a83526e"
    }
  },
  {
    "ts": null,
    "headline": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
    "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
    "url": "https://finnhub.io/api/news?id=29bda3e91c05f1eff9543fd18991f8fc0bea52076ad8d57b4e18e77cb1c103fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763059500,
      "headline": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
      "id": 137473211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
      "url": "https://finnhub.io/api/news?id=29bda3e91c05f1eff9543fd18991f8fc0bea52076ad8d57b4e18e77cb1c103fb"
    }
  },
  {
    "ts": null,
    "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=5aafec13e5283a7c16cdd2ef7a281b860ab6773670749212b5df63a2284578b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763045138,
      "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
      "id": 137468541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=5aafec13e5283a7c16cdd2ef7a281b860ab6773670749212b5df63a2284578b0"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=cedb7ace54d09fdb8117ad47f7a1120ff22611af65dac9fff25fc9fcef1f3c3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763044802,
      "headline": "Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock",
      "id": 137469255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=cedb7ace54d09fdb8117ad47f7a1120ff22611af65dac9fff25fc9fcef1f3c3b"
    }
  },
  {
    "ts": null,
    "headline": "RNAi looked doomed to fail — until Alnylam’s science chief found a way",
    "summary": "Kevin Fitzgerald, Alnylam Pharmaceuticals’ chief scientific officer, reveals the hard times that led to RNAi success, and what it takes to pave new roads in biotech.",
    "url": "https://finnhub.io/api/news?id=3da581b82aa92aa82b22ca12c7d6cb3a258cf6a172ea1b8fe2c588411bc0cc06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763020800,
      "headline": "RNAi looked doomed to fail — until Alnylam’s science chief found a way",
      "id": 137470187,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Kevin Fitzgerald, Alnylam Pharmaceuticals’ chief scientific officer, reveals the hard times that led to RNAi success, and what it takes to pave new roads in biotech.",
      "url": "https://finnhub.io/api/news?id=3da581b82aa92aa82b22ca12c7d6cb3a258cf6a172ea1b8fe2c588411bc0cc06"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
    "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
    "url": "https://finnhub.io/api/news?id=89be9136e46271c1f51fa719d9a1970ed88a7ab94b062f94212b3f46955971d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762997220,
      "headline": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
      "id": 137467043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
      "url": "https://finnhub.io/api/news?id=89be9136e46271c1f51fa719d9a1970ed88a7ab94b062f94212b3f46955971d9"
    }
  }
]